🇺🇸 FDA
Patent

US 11419883

Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes

granted A61KA61K31/12A61K31/145

Quick answer

US patent 11419883 (Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes) held by The Regents of the University of California expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/12, A61K31/145, A61K31/353, A61K31/366